Xiang-rong Zuo
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Evaluation and Treatment of Endoplasmic Reticulum (ER) Stress in Right Ventricular Dysfunction during Monocrotaline-Induced Rat Pulmonary Arterial Hypertension.
Journal: Cardiovascular drugs and therapy
Published: November 16, 2016
Clinical characteristics of 161 Chinese patients with idiopathic pulmonary arterial hypertension
Journal: Zhonghua xin xue guan bing za zhi
Published: November 13, 2012
Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats.
Journal: International immunopharmacology
Published: September 20, 2012
Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats.
Journal: Vascular pharmacology
Published: April 26, 2012
The effects of siRNA against RPL22 on ET-1-induced proliferation of human pulmonary arterial smooth muscle cells.
Journal: International journal of molecular medicine
Published: February 27, 2012
Usefulness of intravenous adenosine in idiopathic pulmonary arterial hypertension as a screening agent for identifying long-term responders to calcium channel blockers.
Journal: The American journal of cardiology
Published: November 27, 2011
Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension.
Journal: PloS one
Published: October 04, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026